期刊文献+

Appraising the causal effects of circulating micronutrients on liver cirrhosis:Evidence from large-scale Mendelian randomization analysis

原文传递
导出
摘要 Aims:Observational research has identified links between micronutrient levels and chronic liver disease.However,the lack of randomized controlled experiments has impeded the ability to establish a cause-and-effect connection regarding micronutrients and cirrhosis of the liver.This Mendelian randomization(MR)analysis aimed to examine the causal impact of micronutrients on liver cirrhosis.Methods:We selected genetic instrumental variables related to 12 micronutrients from genome-wide studies on individuals of European descent,covering an array of over 9,851,867 single nucleotide polymorphisms and 460,351 participants.Data from patients with cirrhosis in the FinnGen database(https://www.finngen.fi/fi)were used.A two-sample MR approach was employed to establish genetically causal estimates.Primary analyses used random effects and inverse variance weighted(IVW)methods,with additional sensitivity analyses for validation.MR–Egger intercept analysis and Cochran's Q test assessed horizontal pleiotropy and heterogeneity.Furthermore,multivariable Mendelian randomization(MVMR)was conducted to address potential confounding variables.Results:IVW and weighted median methods showed that most micronutrients included were not significantly associated with a genetic susceptibility to liver cirrhosis.However,MR analysis demonstrated a significant association between circulating vitamin D levels and a reduced risk of liver cirrhosis(odds ratio IVW=0.53,p<0.010).TheMR–Egger intercept showed no evidence of horizontal pleiotropy(p=0.178),whereas Cochran's Q test found no heterogeneity(p=0.799).Furthermore,MVMR analysis confirmed vitamin D was identified as a factor that independently mitigates the risk of liver cirrhosis.Conclusion:This research constitutes the most comprehensive MR investigation in this field,providing evidence supporting a protective link between circulating vitamin D levels and cirrhosis incidence.It suggests that maintaining sufficient vitamin D could be a cost-effective strategy for early intervention in liver cirrhosis.
出处 《Portal Hypertension & Cirrhosis》 2024年第3期160-170,共11页 门静脉高压与肝硬化(英文)
基金 Guangdong Basic and Applied Basic Research Foundation,Grant/Award Numbers:2023A1515012531,2022A1515010537 Guangzhou Science and Technology Project,Grant/Award Number:2024B03J1256。
  • 相关文献

参考文献2

二级参考文献13

  • 1Edmondo Falleti,Davide Bitetto,Carlo Fabris,Annarosa Cussigh,Elisabetta Fontanini,Ezio Fornasiere,Elisa Fumolo,Sara Bignulin,Sara Cmet,Rosalba Minisini,Mario Pirisi,Pierluigi Toniutto.Vitamin D receptor gene polymorphisms and hepatocellular carcinoma in alcoholic cirrhosis[J].World Journal of Gastroenterology,2010,16(24):3016-3024. 被引量:14
  • 2S. Yokoyama,S. Takahashi,Y. Kawakami,C. N. Hayes,H. Kohno,H. Kohno,K. Tsuji,Y. Aisaka,S. Kira,K. Yamashina,M. Nonaka,T. Moriya,M. Kitamoto,S. Aimitsu,T. Nakanishi,H. Kawakami,K. Chayama.Effect of vitamin D supplementation on pegylated interferon/ribavirin therapy for chronic hepatitis C genotype 1b: a randomized controlled trial[J].J Viral Hepat.2014(5)
  • 3Eric Trépo,Romy Ouziel,Pierre Pradat,Yukihide Momozawa,Eric Quertinmont,Christine Gervy,Thierry Gustot,Delphine Degré,Vincent Vercruysse,Pierre Deltenre,Laurine Verset,Beatrice Gulbis,Denis Franchimont,Jacques Devière,Arnaud Lemmers,Christophe Moreno.Marked 25-hydroxyvitamin D deficiency is associated with poor prognosis in patients with alcoholic liver disease&lt;!-- Doctopic: GMD --&gt;[J].Journal of Hepatology.2013(2)
  • 4Sérgio Bucharles,Silvio Henrique Barberato,Andréa E.M. Stinghen,Betina Gruber,Luciana Piekala,Ana Cláudia Dambiski,Melani R. Custodio,Roberto Pecoits-Filho.Impact of Cholecalciferol Treatment on Biomarkers of Inflammation and Myocardial Structure in Hemodialysis Patients Without Hyperparathyroidism[J].Journal of Renal Nutrition.2012(2)
  • 5Ansar A. Khan,Edwin C.Y. Chow,Anne-miek M.A. van Loenen-Weemaes,Robert J. Porte,K. Sandy Pang,Geny M.M. Groothuis.Comparison of effects of VDR versus PXR, FXR and GR ligands on the regulation of CYP3A isozymes in rat and human intestine and liver[J].European Journal of Pharmaceutical Sciences.2009(2)
  • 6Emilie D’Aldebert,Marie–Jeanne Biyeyeme Bi Mve,Martine Mergey,Dominique Wendum,Delphine Firrincieli,Audrey Coilly,Laura Fouassier,Christophe Corpechot,Raoul Poupon,Chantal Housset,Nicolas Chignard.Bile Salts Control the Antimicrobial Peptide Cathelicidin Through Nuclear Receptors in the Human Biliary Epithelium[J].Gastroenterology.2009(4)
  • 7Atsushi Tanaka,Saeko Nezu,Satoko Uegaki,Kentaro Kikuchi,Akitaka Shibuya,Hiroshi Miyakawa,Shin-ichi Takahashi,Ilaria Bianchi,Paola Zermiani,Mauro Podda,Hiromasa Ohira,Pietro Invernizzi,Hajime Takikawa.Vitamin D receptor polymorphisms are associated with increased susceptibility to primary biliary cirrhosis in Japanese and Italian populations[J].Journal of Hepatology.2009(6)
  • 8Whitney S. Goldner,Julie A. Stoner,Jon Thompson,Karen Taylor,Luann Larson,Judi Erickson,Corrigan McBride.Prevalence of Vitamin D Insufficiency and Deficiency in Morbidly Obese Patients: A Comparison with Non-Obese Controls[J].Obesity Surgery.2008(2)
  • 9Janus P. Ong,Zobair M. Younossi.Epidemiology and Natural History of NAFLD and NASH[J].Clinics in Liver Disease.2007(1)
  • 10Giovanni Targher,Lorenzo Bertolini,Luca Scala,Massimo Cigolini,Luciano Zenari,Giancarlo Falezza,Guido Arcaro.Associations between serum 25-hydroxyvitamin D 3 concentrations and liver histology in patients with non-alcoholic fatty liver disease[J].Nutrition Metabolism and Cardiovascular Diseases.2006(7)

共引文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部